CClinicalTrials.gg
Not yet recruitingNCT05948163Updated Nov 2, 2023

Caries Risk Assessment in Egyptian Children in Mixed Dentition Stage

An observational study in Caries Risk Assesment, sponsored by Cairo University. Not yet recruiting. Open to participants aged 6 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-02.

Sponsored by Cairo University · Observational

From the registry’s dates

  • Primary completion was expected by May 2024, 2 years 5 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
296
Ages
6 Years to 12 Years
Sex
All
01

Study summary

This study aim to assess the validity of ADA caries risk assessment tool on the Egyptian Children in mixed dentition stage .

Read the detailed description

Dental caries is the most common chronic disease of childhood that causes health problems such as pain and infection in children reducing their quality of life.

Risk for caries includes physical, biological, environmental, behavioral, and lifestyle-related factors as insufficient fluoride exposure, poor oral hygiene,inappropriate methods of feeding infants, and poorness .

Risk is a probability that an event will occur. Caries Risk Assessment (CRA) is "prediction of future caries based on the diagnosis of current disease by evaluation of risk and protective factors for making evidence-based clinical decisions. Individual risk assessment constitutes the cornerstone of the treatment plan for the management of early childhood caries for pediatric patients. Caries risk assessment should be included in the treatment plan to facilitate The decision-making process concerning preventive care (both home and office) treatment, recall appointments.

An ideal risk assessment model should be inexpensive, easy to use and time efficient with a high degree of accuracy in caries predictive value.

American Dental Association (ADA) is a tool for caries risk assessment and Management , that when modified to meet the needs of an environment Will be of tremendous use in caries risk assessment. The ADA's mission is to help dentists succeed and support the advancement of the health of the public.

02

Conditions studied

  • Caries Risk Assesment
03

In context

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Children aged 6 to 12 years

Inclusion criteria

  • Children age range from 6 to 12 years.
  • Apparently healthy children.
  • Children affected by dental caries.
  • Parents acceptance for their children's participation in the study.

Exclusion criteria

Exclusion Criteria:

  • Children on long-term medication.
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
296 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Caries Risk Assessment using ADA

    Measurement Method Questions Measurement Method :Questions

    Time frame: one year

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 2, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05948163
Lead sponsor
Cairo University
Responsible party
Noha Yehia Zekry Ibrahim (Doctor, Cairo University) — Principal investigator
First posted
Jul 17, 2023
Start date
Nov 1, 2023 (estimated)
Primary completion
May 1, 2024 (estimated)
Completion
Jul 1, 2024 (estimated)
Last update
Nov 2, 2023

Study contacts

Noha Y Ibrahim, Master
Contact
drnoha080@gmail.com
01064362618

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion